The Valiant Laboratories IPO subscription status has started on September 27, 2023, and it is also being subscribed by QIB, NII, and RII. The Valiant Laboratories IPO began on 27 September 2023 ans closes on 03 October 2023. Valiant Laboratories IPO is preparing to raise ₹152.46 crores through its fresh issue and the Valiant Laboratories IPO price band is fixed ₹133 to ₹140 per share. Check out Valiant Laboratories’ IPO GMP here.
The pharmaceutical API industry in India is ranked third-largest globally in terms of volume, behind China and Italy – About 35 per cent of API and intermediaries produced in India are exported and the remaining API and intermediaries are sold in the domestic market, including captive consumption by several large formulation players.
Valiant Laboratories IPO reserved shares in this IPO, 50% for QIB and 15% for NII, and 35% for the retail category have been reserved. To know the Valiant Laboratories IPO Subscription Status, you can see the below-day Subscription.
Valiant Laboratories IPO Review :
| Details | Valuation |
| PAT 2023 : Issue Price : EPS 2023 : PE Ratio : ROE : RoNW : ROCE : Debt/Equity : NAV Value : Total Assets : Market Cap : Pre Holding : Post Holding : | ₹29.00 Cr ₹140 Per Shares 8.91 15.71x 33.73 % 28.86 % 22.76 % 0.59 ₹30.86 ₹212.76 Cr ₹608.30 Cr 100.00 % 74.94 % |
| Team Review : | ✔ Apply For Long Term |
Valiant Laboratories IPO Subscription Status {Live Update} :
The total Valiant Laboratories IPO Subscription Status subscribed 29.76x times so far, with QIB subscribed 20.83x and NII subscribed 73.64x times & RII 16.06x times on Day 4. (Closed)
| Category | Day 1 | Day 2 | Day 3 | Day 4 |
|---|---|---|---|---|
| QIB : | 0.0x | 0.05x | 1.04x | 20.83x |
| NII : _________ bNII (above ₹10L): sNII (below ₹10L): | 0.11x ______ 0.08x 0.16x | 0.29x ______ 0.16x 0.56x | 1.52x ______ 1.06x 2.44x | 73.64x ______ 78.64x 63.64x |
| RII : | 0.62x | 1.29x | 3.14x | 16.06x |
| Total : | 0.33x | 0.72x | 2.19x | 29.76x |
Valiant Laboratories IPO Net Shares Offered:
Valiant Laboratories IPO is a public issue of 10,890,000 equity shares. The issue offers 21,78,030 shares to qualified institutional buyers, 16,33,500 shares to non-institutional investors, and 38,11,500 shares to retail investors.
| Category | Net EQ Offer | Amount(in Cr) |
| Anchor : | 3,266,970 | 45.74 Cr |
| QIB : | 21,78,030 | 30.49 Cr |
| NII : ________________________ bNII (bids above ₹10L) : sNII (bids below ₹10L) : | 16,33,500 ______________ 10,88,999 5,44,501 | 22.87 Cr _______ 15.25 Cr 7.62 Cr |
| RII : | 38,11,500 | 53.36 Cr |
| Total : | 10,890,000 | 152.46 Cr |
Investor Categories Define :
■ Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds, insurance companies, and pension schemes.
■ Non-Institutional Investors(NII): Retail Individual Investors, NRIs, Companies, Trusts, etc
● sNII (bids below Rs 10L): The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category.
● bNII (bids above Rs 10L): The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory.
■ Retail Individual Investors (RII): Retail Individual Investors or NRIs
■ Employee (EMP): Eligible Employees
■ Others: Eligible Shareholders
Valiant Laboratories IPO Subscription Status FAQs :
How much was the total Valiant Laboratories IPO Subscription Status?
The total Valiant Laboratories IPO Subscription Status 29.76x times Day 4.
What is the Valiant Laboratories IPO retail subscription Status?
Valiant Laboratories IPO Retail Subscription 16.06x times Day 4.
How much is the Valiant Laboratories IPO QIB subscription Status?
The Valiant Laboratories IPO QIB subscription 20.83x times Day 4.
How much did Valiant Laboratories IPO NII subscribe?
Valiant Laboratories IPO NII Subscription 73.64x times Day 4.
What is Valiant Laboratories IPO Investors Portion?
The investors’ portion for QIB 50%, NII 15%, RII 35%.
What is Valiant Laboratories IPO Allotment Date?
Valiant Laboratories IPO allotment date is 06 October 2023.
What is Valiant Laboratories IPO Listing Date?
Valiant Laboratories IPO listing date is 11 October 2023. The IPO to list on NSE, BSE.
How to Apply the Valiant Laboratories IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Valiant Laboratories IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Valiant Laboratories IPO through Upstox?
Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Valiant Laboratories IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Valiant Laboratories IPO through Groww?
Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Valiant Laboratories IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Valiant Laboratories IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Valiant Laboratories IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Valiant Laboratories IPO GMP: Click Here Valiant Laboratories IPO Details: Click Here Valiant Laboratories IPO Allotment: Click Here Valiant Laboratories IPO Listing: Click Here |
All Valiant Laboratories IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.